Geode Capital Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.72M | Buy |
|
|||||
2025
Q1 | $4.38M | Buy |
|
|||||
2024
Q4 | $4.27M | Buy |
|
|||||
2024
Q3 | $2.48M | Buy |
|
|||||
2024
Q2 | $2.02M | Buy |
|
|||||
2024
Q1 | $2.32M | Buy |
|
|||||
2023
Q4 | $628K | Buy |
|
|||||
2023
Q3 | $545K | Buy |
|
|||||
2023
Q2 | $560K | Sell |
|
|||||
2023
Q1 | $682K | Hold |
|
|||||
2022
Q4 | $578K | Sell |
|
|||||
2022
Q3 | $638K | Buy |
|
|||||
2022
Q2 | $906K | Sell |
|
|||||
2022
Q1 | $1.66M | Buy |
|
|||||
2021
Q4 | $3.88M | Buy |
|
|||||
2021
Q3 | $3.88M | Buy |
|
|||||
2021
Q2 | $3.42M | Buy |
|
|||||
2021
Q1 | $1.93M | Buy |
|
|||||
2020
Q4 | $3.65M | Buy |
|
|||||
2020
Q3 | $1.51M | Buy |
|
|||||
2020
Q2 | $201K | Buy |
|
|||||
2020
Q1 | $16K | Hold |
|
|||||
2019
Q4 | $20K | Hold |
|
|||||
2019
Q3 | $25K | Hold |
|
|||||
2019
Q2 | $41K | Hold |
|
|||||
2019
Q1 | $62K | Buy |
|
|||||
2018
Q4 | $52K | Hold |
|
|||||
2018
Q3 | $81K | Buy |
|
|||||
2018
Q2 | $8K | Hold |
|
|||||
2018
Q1 | $48K | Hold |
|
|||||
2017
Q4 | $42K | Sell |
|
|||||
2017
Q3 | $109K | Hold |
|
|||||
2017
Q2 | $188K | Sell |
|
|||||
2017
Q1 | $227K | Buy |
|
|||||
2016
Q4 | $393K | Buy |
|
|||||
2016
Q3 | $837K | Buy |
|
|||||
2016
Q2 | $833K | Buy |
|
|||||
2016
Q1 | $853 | Buy |
|
|||||
2015
Q4 | $977K | Buy |
|
|||||
2015
Q3 | $996K | Buy |
|
|||||
2015
Q2 | $1.45M | Buy |
|
|||||
2015
Q1 | $667K | Buy |
|
|||||
2014
Q4 | $353K | Buy |
|
|||||
2014
Q3 | $299K | Hold |
|
|||||
2014
Q2 | $229K | Hold |
|
|||||
2014
Q1 | $375K | Hold |
|
|||||
2013
Q4 | $375K | Hold |
|
|||||
2013
Q3 | $470K | Buy |
|
|||||
2013
Q2 | $264K | Buy |
|